Novo Nordisk A S NVO
NYSE NVO
$46.18 -0.29 (-0.62%)
At close: Aug 20, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) Net Margin (2012 - 2016)

Novo Nordisk A S's (NVO) quarterly Net Margin came in at 36.28% in Q2 2016, up 553.0% YoY from 5.56% in Q3 2015, and up 4.39% on a QoQ basis from 34.75% in Q1 2016.

Novo Nordisk A S (NVO) Net Margin (2012 - 2016) Analysis & Trends

Novo Nordisk A S (NVO) has 5 years of Net Margin data on file, last reported at 36.28% in Q2 2016.

  • Quarterly Net Margin rose 553.0% year-over-year to 36.28% in Q2 2016, while the trailing twelve-month figure through Jun 2016 was 32.69% (up 148.0% YoY) and the FY2019 annual result came in at 145.95%, up 465.0% from the prior year.
  • Net Margin advanced to 36.28% in Q2 2016, from 34.75% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 40.62% in Q2 2013 to a low of 26.31% in Q4 2014.
  • A 5-year average of 34.37% and a median of 35.16% in 2016 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2014 — Net Margin slumped 1130 bps — and 2015, when it surged 745 bps.
  • Tracing NVO's Net Margin over 5 years: stood at 35.57% in 2012, then gained by 1 bps to 36.0% in 2013, then fell by 27 bps to 26.31% in 2014, then advanced by 8 bps to 28.54% in 2015, then increased by 27 bps to 36.28% in 2016.
  • The last three Net Margin figures came in at 36.28% (Q2 2016), 34.75% (Q1 2016), and 28.54% (Q4 2015), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2016 36.28%
Mar 31, 2016 34.75%
Dec 31, 2015 28.54%
Sep 30, 2015 31.30%
Jun 30, 2015 30.74%
Mar 31, 2015 39.18%
Dec 31, 2014 26.31%
Sep 30, 2014 29.14%
Jun 30, 2014 32.35%
Mar 31, 2014 31.74%
Dec 31, 2013 36.00%
Sep 30, 2013 40.43%
Jun 30, 2013 40.62%
Mar 31, 2013 38.87%
Dec 31, 2012 35.57%
Sep 30, 2012 37.13%
Jun 30, 2012 35.66%
Mar 31, 2012 34.13%